Yonsei University: Adenocarcinoma trials

The registry lists 10 Adenocarcinoma studies with Yonsei University as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 6Phase 3 1Phase 4 1No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Intracorporeal Versus Extracorporeal Anastomosis In Laparoscopic Right Colon ResectionStatus unknownNCT05077358Not applicable
• A Phase 2 Trial of Neoadjuvant Modified FOLFIRINOX Chemotherapy for Resectable Pancreatic AdenocarcinomaStatus unknownNCT05066802Phase 2
• Prospective Study of Oncologic Outcomes After Laparoscopic Modified Complete Mesocolic Excision for Non-metastatic Right Colon Cancer [PIONEER Study]Status unknownNCT03992599
• Preoperative Chemoradiotherapy for Locally Advanced Resectable Gastric AdenocarcinomaCompletedNCT03814759Phase 2
• PI3Kβ Selective Inhibitor With Paclitaxel, Advanced Gastric AdenocarcinomaCompletedNCT02615730Phase 1/2
• Prevention of Upper Gastrointestinal Hemorrhage Using Albis® in the Patients of Locally Advanced Pancreatic Cancer Who Underwent Concurrent ChemoradiotherapyWithdrawnNCT02570529Phase 4
• S-1, Cisplatin-based Chemoradiotherapy, Induction Chemotherapy, Locally Advanced Gastric AdenocarcinomaCompletedNCT02495493Phase 2
• Modified FOLFIRINOX for Gemcitabine Refractory Pancreatic Cancer: A Phase II Multicenter TrialCompletedNCT02440958Phase 2
• Neoadjuvant Combination Chemotherapy of DCS and DCF in Patients With Locally Advanced Gastric AdenocarcinomaCompletedNCT01286766Phase 2
• Docetaxel and S1 (DS) Versus S1 and Cisplatin (SP) in Curatively Resected Stage IIIB/IV Gastric CancerStatus unknownNCT01283217Phase 3